Stay updated on Combining MK-3475 and SBRT in Metastatic Melanoma or NSCLC Clinical Trial
Sign up to get notified when there's something new on the Combining MK-3475 and SBRT in Metastatic Melanoma or NSCLC Clinical Trial page.

Latest updates to the Combining MK-3475 and SBRT in Metastatic Melanoma or NSCLC Clinical Trial page
- Check7 days agoNo Change Detected
- Check15 days agoChange DetectedThe page’s footer shows an updated platform/release revision from v3.5.2 to v3.5.3, with no changes to the displayed clinical study information.SummaryDifference0.1%

- Check22 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check29 days agoNo Change Detected
- Check51 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0. This update is administrative and does not affect study details or user interactions.SummaryDifference0.1%

- Check65 days agoChange DetectedRevision metadata updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check87 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check94 days agoChange DetectedRevision history updated: added revision v3.4.1 and removed v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Combining MK-3475 and SBRT in Metastatic Melanoma or NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Combining MK-3475 and SBRT in Metastatic Melanoma or NSCLC Clinical Trial page.